These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19271278)

  • 1. Rosuvastatin in patients with elevated C-reactive protein.
    Davis CE
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271278
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosuvastatin in patients with elevated C-reactive protein.
    Pierard LA
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Sniderman AD
    Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Less vascular risk with rosuvastatin in elevated CRP].
    Bredie B
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):245. PubMed ID: 19271446
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies examine inflammatory biomarker in prevention and prediction of heart disease.
    Mitka M
    JAMA; 2009 Jan; 301(1):23-4. PubMed ID: 19126804
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Rosenstein R; Parra D
    Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Danchin N
    Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Feeman WE
    Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding the orbit of primary prevention--moving beyond JUPITER.
    Hlatky MA
    N Engl J Med; 2008 Nov; 359(21):2280-2. PubMed ID: 18997195
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin in patients with elevated C-reactive protein.
    Koller MT; Bucher HC; Steyerberg EW
    N Engl J Med; 2009 Mar; 360(10):1041; author reply 1041-2. PubMed ID: 19271276
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosuvastatin in patients with elevated C-reactive protein.
    Chan PS; Nallamothu BK; Hayward RA
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    de Tena JG
    Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Segura J; Ruilope LM
    Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Bloom JM
    Lancet; 2009 Jul; 374(9683):25-6; author reply 26-7. PubMed ID: 19577688
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosuvastatin in patients with elevated C-reactive protein.
    Gibbons RJ
    N Engl J Med; 2009 Mar; 360(10):1038; author reply 1041-2. PubMed ID: 19264695
    [No Abstract]   [Full Text] [Related]  

  • 17. JUPITER clinical directions--polling results.
    Kritek P; Campion EW
    N Engl J Med; 2009 Mar; 360(10):e14. PubMed ID: 19264683
    [No Abstract]   [Full Text] [Related]  

  • 18. The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER.
    Chapman MJ; Giral P; Barter PJ
    Eur Heart J; 2013 May; 34(18):1318-20. PubMed ID: 23482520
    [No Abstract]   [Full Text] [Related]  

  • 19. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
    Lubsen J
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
    [No Abstract]   [Full Text] [Related]  

  • 20. Jupiter to Earth: CRP promotes atherothrombosis.
    Jialal I; Devaraj S
    Metab Syndr Relat Disord; 2009 Feb; 7(1):1-3. PubMed ID: 19183073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.